Fdc Ltd. Share Price & Stock Analysis

Fdc Ltd. (BSE: 531599) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹6,358 Cr, it ranks #756 by market cap among the 6,197 Indian listed companies on FinBizNet, and #21 of 86 in Medicinal Chemicals and Botanical Products. At ₹371.45 (as of 16 Nov 2026), the share price is 16.0% below its 52-week high of ₹442.00 and 18.7% above its 52-week low of ₹312.95. The share price is down 12.7% over one year and up 3.7% over three months.

Key Metrics

Current Price₹371.45
Market Cap₹6,358 Cr
BSE Code531599
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio22.6
Return on Equity11.81%
Return on Assets6.37%
52-Week Range₹312.95 – ₹442.00
1-Year Price Change-12.7%
3-Month Price Change+3.7%
Beta (1Y)0.16
Dividend Yield2.56%
HeadquartersMumbai, Maharashtra
Websitewww.fdcindia.com

Latest Quarterly Results — Q2 FY27

Revenue₹572 Cr
Net Profit₹49 Cr
Net Margin8.6%
EPS (Basic)₹3.01
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Fdc Ltd. Quarterly Revenue and Profit Trend

Fdc Ltd. reported revenue of ₹572 Cr in Q2 FY27, up 21.0% from ₹473 Cr in Q2 FY26 and down 14.3% from ₹668 Cr in Q1 FY27. It posted a net profit of ₹49 Cr for the quarter, against a net profit of ₹28 Cr in Q2 FY26 (up 72.9%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹465 Cr (Q3 FY26) to ₹668 Cr (Q1 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹572 Cr₹49 Cr8.6%
Q1 FY27₹668 Cr₹132 Cr19.8%
Q4 FY26₹585 Cr₹103 Cr17.7%
Q3 FY26₹465 Cr₹28 Cr6.1%
Q2 FY26₹473 Cr₹28 Cr6.0%
Q1 FY26₹648 Cr₹121 Cr18.7%
Q4 FY25₹492 Cr₹39 Cr7.9%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 69.66% of Fdc Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 51.7% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Fdc Ltd.

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to app

Products and Services

1. Pharmaceuticals-This segment engages in the pharmaceutical business.

Business Segments

1. Pharmaceuticals-100%

Fdc Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Fdc Ltd.₹6,358 Cr22.611.81%₹572 Cr-12.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Fdc Ltd.?

Fdc Ltd. is trading at ₹371.45, with a market capitalisation of ₹6,358 Cr.

Which sector does Fdc Ltd. belong to?

Fdc Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Fdc Ltd.?

Fdc Ltd. has a P/E of 22.6 and a return on equity of 11.81%.

What is the stock symbol of Fdc Ltd.?

Fdc Ltd. is listed on the BSE under the scrip code 531599.

How has Fdc Ltd.'s share price moved over the past year?

Fdc Ltd.'s share price is down 12.7% over one year and up 3.7% over three months. Its 52-week range is ₹312.95 to ₹442.00.

What were Fdc Ltd.'s latest quarterly results?

In Q2 FY27, Fdc Ltd. reported revenue of ₹572 Cr and net profit of ₹49 Cr, with basic EPS of ₹3.01 (consolidated, parsed from the company's exchange filing).

How have Fdc Ltd.'s revenue and profit changed over the past year?

Fdc Ltd. reported revenue of ₹572 Cr in Q2 FY27, up 21.0% from ₹473 Cr in Q2 FY26 and down 14.3% from ₹668 Cr in Q1 FY27.

What is the promoter holding in Fdc Ltd.?

Promoters held 69.66% of Fdc Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.